NKGN (NKGen Biotech) PB Ratio : (As of Dec. 15, 2024)

View and export this data going back to 2023. Start your Free Trial

What is NKGen Biotech PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-15), NKGen Biotech's share price is $0.4998. NKGen Biotech's Book Value per Share for the quarter that ended in Jun. 2024 was $-2.71. Hence, NKGen Biotech's PB Ratio of today is .

The historical rank and industry rank for NKGen Biotech's PB Ratio or its related term are showing as below:

During the past 3 years, NKGen Biotech's highest PB Ratio was 91.70. The lowest was 0.00. And the median was 0.00.

NKGN's PB Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.48
* Ranked among companies with meaningful PB Ratio only.

Back to Basics: PB Ratio

NKGen Biotech PB Ratio Historical Data

The historical data trend for NKGen Biotech's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKGen Biotech PB Ratio Chart

NKGen Biotech Annual Data

Trend

Dec21

Dec22

Dec23

PB Ratio

NKGen Biotech Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
PB Ratio	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of NKGen Biotech's PB Ratio

For the Biotechnology subindustry, NKGen Biotech's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NKGen Biotech's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NKGen Biotech's PB Ratio distribution charts can be found below:

* The bar in red indicates where NKGen Biotech's PB Ratio falls into.

NKGen Biotech PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

NKGen Biotech's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Jun. 2024)
	=	0.4998	/	-2.705
	=

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

NKGen Biotech (NAS:NKGN) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

NKGen Biotech PB Ratio Related Terms

Thank you for viewing the detailed overview of NKGen Biotech's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

NKGen Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

3001 Daimler Street, Santa Ana, CA, USA, 92705

Website

https://www.nkgenbiotech.com

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.